Skip to main content
KBS_Icon_questionmark link-ico

Go to…

Course offers students rare insight into the pharmaceutical industry

A new course designed to explore the development and management of medicines has launched at King’s.

Medicines

The MSc course in Medical Affairs, at The Centre for Pharmaceutical Medicine Research within the Institute of Pharmaceutical Sciences, believed to be the world’s first ever University Masters degree course in Medical Affairs, The course will run alongside the Centre’s established and highly successful MSc courses in Clinical Pharmacology and in Drug Development Science.

The new MSc is modular in design, and available for either full-time or part-time study. It is open for applications from the 1st October 2020, with the first full-time students beginning their studies in September 2021.

The course has been designed to meet the needs of graduates in medicine, pharmacy or other life sciences, looking for their first job within the pharmaceutical industry, and to those who are already employed and looking to broaden their knowledge and help their career progression.

This MSc in Medical Affairs has been designed by highly experienced industry experts, and the lectures will be given by a mix of professional academics and senior employees of pharmaceutical companies and regulatory authorities.

 

The launch of our new MSc in Medical Affairs represents an exciting milestone in the provision of education in this field at King’s, and will provide a focus for an expansion of the Centre for Pharmaceutical Medicine Research activities in this key area.– Dr Stuart Jones, Reader in Pharmaceutics and Course Director of the MSc programme

Prof Peter Stonier, Director of Education and Training at the Faculty of Pharmaceutical Medicine of the Royal Colleges of Physicians, UK, said: “This new course will provide much-needed educational support for the area of medical affairs, which is a growing and increasingly strategic branch of industry in the development of medicines and medical devices”.

Dr Pol Vandenbroucke, Chief Medical Officer, Hospital BU Pfizer Inc, said that “the course fills a global need for the professionalisation of the Medical Affairs discipline worldwide”.

In this story

Stuart Jones

Stuart Jones

Reader in Pharmaceutics